Startup from Kazakhstan to enter Uzbekistan’s market

Published
Cerebra, a medical startup from Kazakhstan is going to test its technology in Uzbekistan

Cerebra is entering Uzbekistan’s market, after receiving funding from Timur Turlov, CEO of Freedom Holding Corp. in June 2021. The company is going to launch its pilot project at the base of two Uzbek clinics, according to the press service of Astana Hub.

Cerebra is an IT company from Almaty that has been working in the area of artificial intelligence since 2018. The company’s software helps neurobiologists to disclose cerebral thrombosis within a ten-minute test. The program is now available in 18 consultant centers across Kazakhstan.

According to Doszhan Zhussupov, head of the project, the company has got several offers from foreign companies to cooperate and work together.

«Our company is going to enter foreign markets; we have already had some arrangements. However, we are still a startup and we need to show investors that the project is worth its investments. Uzbekistan is the very first county outside Kazakhstan that has officially joined the project,» said Zhussupov.

According to Ernst & Young, Cerebra is the best innovative startup, which also ranked in the top ten MedTech projects from all over the world.

In June 2021 Cerebra attracted $1 million from Timur Turlov, CEO of Freedom Holding Corp. As Doszhan Zhussupov predicts, in the near future specialized medical screening systems based on AI will be available. These systems will help health specialists to diagnose serious diseases and pathologies with a high level of precision.

Read also